Code Pharma is Initiating a Phase 2 Controlled Study | Global Trend Monitor

Zyon Ayni - Global Trend Monitor

Zyon Ayni, Founder and CEO of Code Pharma, talked to Global Trend Monitor about the phase 1 study of Codivir, a medication that battles COVID-19: “The trial was conducted at Casa de Saúde, Vera Cruz Hospital in São Paulo, Brazil, with Dr Florentino Cardoso and results showed that Codivir has a high safety profile while … Read more